Novo Integrated Sciences PE Ratio 2012-2024 | NVOS

Current and historical p/e ratio for Novo Integrated Sciences (NVOS) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Novo Integrated Sciences PE ratio as of June 24, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Novo Integrated Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-06-24 0.77 0.00
2024-02-29 0.63 $-0.54 0.00
2023-11-30 1.20 $-0.98 0.00
2023-08-31 0.14 $-1.90 0.00
2023-05-31 0.13 $-9.50 0.00
2023-02-28 0.13 $-10.70 0.00
2022-11-30 0.25 $-11.80 0.00
2022-08-31 1.67 $-11.30 0.00
2022-05-31 2.05 $-4.50 0.00
2022-02-28 1.39 $-3.40 0.00
2021-11-30 1.44 $-2.30 0.00
2021-08-31 1.82 $-1.60 0.00
2021-05-31 2.22 $-0.80 0.00
2021-02-28 5.21 $-0.60 0.00
2020-11-30 0.36 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.016B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00